We have previously shown that exercise training prevents arrhythmias in CPVT1, potentially by reducing the oxidation of Ca2+/calmodulin‐dependent protein kinase type II (CaMKII). This evidence concerns the gene CAMK2G and catecholaminergic polymorphic ventricular tachycardia 1.